Analysts expect BIO-TECHNE Corp to report revenue of 317.67 M for Q2 27, against a range of 293.73 M to 341.61 M. The most recent reported quarter, Q1 27, came in at 299.71 M, a 0.3% miss against the 300.50 M consensus.
| Metric | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 297.03 M | 316.18 M | 316.96 M | 286.56 M | 295.88 M | 311.42 M | 321.19 M | 299.71 M | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 300.14 M | 354.82 M | 358.60 M | 306.64 M | 282.50 M | 326.10 M | 324.74 M | 321.42 M | 341.61 M | 365.33 M | 350.85 M | 363.51 M | 358.84 M | 360.70 M | 413.06 M | 373.96 M | |||||||||||
| Low Estimate | 247.70 M | 320.25 M | 307.98 M | 251.18 M | 262.77 M | 285.27 M | 289.21 M | 279.59 M | 293.73 M | 319.66 M | 289.74 M | 305.33 M | 318.19 M | 318.54 M | 346.27 M | 341.59 M | |||||||||||
| Consensus Estimate | 273.92 M | 337.53 M | 333.29 M | 278.91 M | 272.63 M | 305.69 M | 306.97 M | 300.50 M | 317.67 M | 342.50 M | 320.29 M | 334.42 M | 338.52 M | 339.62 M | 379.67 M | 357.78 M |
Analysts expect BIO-TECHNE Corp to report earnings per share of 0.46 for Q2 27, against a range of 0.44 to 0.48. The most recent reported quarter, Q1 27, came in at 0.44, a 6.4% miss against the 0.47 consensus.
| Metric | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.42 | 0.56 | 0.53 | 0.42 | 0.46 | 0.53 | 0.52 | 0.44 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 0.42 | 0.54 | 0.56 | 0.48 | 0.49 | 0.59 | 0.54 | 0.50 | 0.48 | 0.62 | 0.61 | 0.58 | 0.60 | 0.69 | 0.67 | 0.62 | |||||||||||
| Low Estimate | 0.38 | 0.44 | 0.46 | 0.40 | 0.41 | 0.53 | 0.46 | 0.44 | 0.44 | 0.54 | 0.57 | 0.52 | 0.54 | 0.59 | 0.59 | 0.54 | |||||||||||
| Consensus Estimate | 0.40 | 0.49 | 0.51 | 0.44 | 0.45 | 0.56 | 0.50 | 0.47 | 0.46 | 0.58 | 0.59 | 0.55 | 0.57 | 0.64 | 0.63 | 0.58 |
Pull Wall Street consensus for BIO-TECHNE Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TECH&mode=revenue&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TECH", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/estimates?ticker=TECH&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();